8,050,000 Shares of Common Stock Point Therapeutics, Inc. (a Delaware corporation) Common Stock Underwriting AgreementUnderwriting Agreement • November 22nd, 2005 • Point Therapeutics Inc • Pharmaceutical preparations • Delaware
Point Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the Underwriters named in Schedule I annexed hereto (the “Underwriters”) an aggregate of 8,050,000 shares of Common Stock, $0.01 par value per share (the “Common Stock”), of the Company (the “Firm Shares”). In addition, solely for the purpose of covering over-allotments, the Company proposes to grant to the Underwriters the option to purchase from the Company up to an additional 1,207,500 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares (to the extent the aforementioned option is exercised) are herein collectively referred to as the “Offered Securities.”
